Venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.

Authors

null

Hannah Dysinger McLaughlin

University of Michigan Hospital, Ann Arbor, MI

Hannah Dysinger McLaughlin , Alli M. Straubhar , Aimee Rolston , Kevin McCool , Melissa Brackmann , Jean Hansen Siedel , Karen McLean , R. Kevin Reynolds , Shitanshu Uppal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5552)

DOI

10.1200/JCO.2023.41.16_suppl.5552

Abstract #

5552

Poster Bd #

247

Abstract Disclosures

Similar Posters

First Author: Luca Antonelli

Poster

2020 ASCO Virtual Scientific Program

Risk of venous thromboembolism in patients receiving neoadjuvant chemotherapy for ovarian cancer.

Risk of venous thromboembolism in patients receiving neoadjuvant chemotherapy for ovarian cancer.

First Author: Derman Basaran

Poster

2020 ASCO Virtual Scientific Program

Venous thromboembolism prophylaxis in ambulatory cancer patients initiating chemotherapy: A cost-effectiveness analysis.

Venous thromboembolism prophylaxis in ambulatory cancer patients initiating chemotherapy: A cost-effectiveness analysis.

First Author: Emma Ryan